发明名称 Antiviral compounds
摘要 The invention provides a pharmaceutical composition comprising: (1) a compound of the formula: or a pharmaceutically acceptable salt thereof; (2) a NS5B polymerase inhibitor; and (3) a NS3 protease inhibitor; and relates to the use of (1), (2) and (3), in combination, in the prophylactic or therapeutic treatment of hepatitis C or a hepatitis C associated disorder.
申请公布号 EP2873665(B1) 申请公布日期 2016.07.06
申请号 EP20140175539 申请日期 2010.05.12
申请人 GILEAD PHARMASSET LLC 发明人 GUO, HONGYAN;KATO, DARRYL;KIRSCHBERG, THORSTENS A.;LIU, HONGTAE;LINK, JOHN O.;MITCHELL, MICHAEL L.;PARRISH, JAY P.;SQUIRES, NEIL;SUN, JIANYU;TAYLOR, JAMES;BACON, ELIZABETH M.;CANALES, EDA;CHO, AESOP;COTTELL, JEROMY J.;DESAI, MANOJ C.;HALCOMB, RANDALL L.;KRYGOWSKI, EVAN S.;LAZERWITH, SCOTT E.;LIU, QI;MACKMAN, RICHARD;PYUN, HYUNG-JUNG;SAUGIER, JOSEPH H.;TRENKLE, JAMES D.;TSE, WINSTON C.;VIVIAN, RANDALL W.;SCHROEDER, SCOTT D.;WATKINS, WILLIAM J.;XU, LIANHONG;YANG, ZHENG-YU;KELLAR, TERRY;SHENG, XIAONING;CLARKE, MICHAEL O'NEIL HANRAHAN;CHOU, CHIEN-HUNG;GRAUPE, MICHAEL;JIN, HAOLUN;MCFADDEN, RYAN;MISH, MICHAEL R.;METOBO, SAMUEL E.;PHILLIPS, BARTON W.;VENKATARAMANI, CHANDRASEKAR;KIM, CHUONG U.
分类号 C07D401/14;A61K31/4184;A61K31/4188;A61K45/06;A61P31/12;C07D471/08;C07F5/02 主分类号 C07D401/14
代理机构 代理人
主权项
地址